Travecta Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Liquidation
Travecta Therapeutics General Information
Description
Developer of a healthcare technology designed to identify candidates that can cross the blood-brain barrier and discover novel neurological pathways. The company's technology designs and screens for highly selective drug molecules that can cross the blood-brain barrier via the MFSD2A transporter protein, enabling physicians to improve the lives of patients with serious neurological diseases.
Contact Information
Website
www.travectatx.comCorporate Office
- 79 Science Park Drive
- Suite 06-01/08
- Singapore, 118264
- Singapore
Corporate Office
- 79 Science Park Drive
- Suite 06-01/08
- Singapore, 118264
- Singapore
Travecta Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 12-Mar-2024 | Completed | Bankruptcy: Liquidation | |||
| 3. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 2. Early Stage VC (Series A) | 12-May-2020 | $27M | $27M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 12-Mar-2018 | Completed | Pre-Clinical Trials |
Travecta Therapeutics Comparisons
Industry
Financing
Details
Travecta Therapeutics Competitors (27)
One of Travecta Therapeutics’s 27 competitors is ICBI, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ICBI | Venture Capital-Backed | San Diego, CA | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Fauna Bio | Venture Capital-Backed | Emeryville, CA | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA |
Travecta Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Travecta Therapeutics Patents
Travecta Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021211436-A1 | Idebenone compounds | Inactive | 13-Apr-2020 | ||
| WO-2021195548-A1 | Oleoylethanolamide compounds | Inactive | 27-Mar-2020 | ||
| WO-2021195555-A1 | Palmitoylethanolamide compounds | Inactive | 27-Mar-2020 | ||
| AU-2020387642-A1 | Process of preparing arachidonoylethanolamine analogues | Inactive | 21-Nov-2019 | ||
| CA-3158052-A1 | Process of preparing arachidonoylethanolamine analogues | Pending | 21-Nov-2019 | C07F9/10 |
Travecta Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Travecta Therapeutics FAQs
-
When was Travecta Therapeutics founded?
Travecta Therapeutics was founded in 2017.
-
Where is Travecta Therapeutics headquartered?
Travecta Therapeutics is headquartered in Singapore, Singapore.
-
What is the size of Travecta Therapeutics?
Travecta Therapeutics has 11 total employees.
-
What industry is Travecta Therapeutics in?
Travecta Therapeutics’s primary industry is Drug Delivery.
-
Is Travecta Therapeutics a private or public company?
Travecta Therapeutics is a Private company.
-
What is Travecta Therapeutics’s current revenue?
The current revenue for Travecta Therapeutics is .
-
How much funding has Travecta Therapeutics raised over time?
Travecta Therapeutics has raised $27M.
-
Who are Travecta Therapeutics’s competitors?
ICBI, Regenxbio, Cerecin, Fauna Bio, and Verge Labs are some of the 27 competitors of Travecta Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
